Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
1 093,811 096,521 100,221 091,51
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
608,77608,77612,97608,77
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
1 254,811 253,011 253,871 226,33
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
1 761,111 764,271 766,881 744,71
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
642,58644,87648,48640,18
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
851,13855,66858,75845,56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
217,98217,98218,65216,88
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
3 211,833 227,213 268,383 226,55
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
948,98948,58957,83941,97
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
1 474,521 479,031 481,041 466,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
2 392,122 396,952 421,222 382,32
VX1:FRA
Vertex Pharmaceuticals Inc
€360,30
0,00%
(0,00) 1D
30 Apr., 12:53:14 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VX1...
Mkt. cap
107,83 mjd
Avg. vol.
43,00
Volume
0,00
52-wk high
€441,20
52-wk low
€313,75
No. of employees
6 k
News stories
From sources across the web
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6,4 k
Founded1989
HeadquartersBoston, Massachusetts, Verenigde State van Amerika
Sector-
Websitevrtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
2,77 mjd
2,96 mjd
3,08 mjd
3,19 mjd
Cost of goods sold
1,34 mjd
1,39 mjd
1,39 mjd
1,44 mjd
Cost of revenue
1,34 mjd
1,39 mjd
1,39 mjd
1,44 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
396,40 m
424,60 m
445,10 m
487,00 m
Operating expense
396,40 m
424,60 m
445,10 m
487,00 m
Total operating expenses
1,74 mjd
1,81 mjd
1,84 mjd
1,93 mjd
Operating income
1,03 mjd
1,15 mjd
1,24 mjd
1,26 mjd
Other non operating income
-1,40 m
9,90 m
14,60 m
-14,30 m
EBT including unusual items
730,40 m
1,28 mjd
1,30 mjd
1,33 mjd
EBT excluding unusual items
1,15 mjd
1,28 mjd
1,35 mjd
1,38 mjd
Income tax expense
84,10 m
250,10 m
215,90 m
139,90 m
Effective tax rate
11,51%
19,49%
16,62%
10,51%
Other operating expenses
-
-
-
-
Net income
646,30 m
1,03 mjd
1,08 mjd
1,19 mjd
Net profit margin
23,33%
34,84%
35,20%
37,34%
Earnings per share
4,06
4,52
4,80
5,03
Interest and investment income
120,90 m
122,40 m
125,70 m
121,90 m
Interest expense
-3,00 m
-3,70 m
-3,30 m
-3,30 m
Net interest expenses
117,90 m
118,70 m
122,40 m
118,60 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,08 mjd
1,21 mjd
1,29 mjd
1,29 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more